Real-time enrollment status for this relapsed sarcomas clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:04 AM UTC
| NCT Number | NCT05210374 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Sarcomas |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Case Comprehensive Cancer Center |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of July 17, 2026: Clinical trial NCT05210374 is currently recruiting participants. This phase1 study for relapsed sarcomas is actively seeking new participants at 1 location across the United States. The study is sponsored by Case Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05210374 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05210374 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.